American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine

CA Cancer Journal for Clinicians

Volumn 66, Issue 5, 2016, Pages 370-374

  Kattan, Michael W ^a,b   Hess, Kenneth R ^c   Amin, Mahul B ^d   Lu, Ying ^e,f   Moons, Karl G M ^g   Gershenwald, Jeffrey E ^c   Gimotty, Phyllis A ^h   Guinney, Justin H ⁱ   Halabi, Susan ^j   Lazar, Alexander J ^c   Mahar, Alyson L ^k   Patel, Tushar ^l   Sargent, Daniel J ^m   Weiser, Martin R ^n,o   Compton, Carolyn ^p,q,r  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e STANFORD UNIVERSITY   (United States)

^f VA Cooperative Studies Program   (United States)

^g UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ SAGE BIONETWORKS   (United States)

^j DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k QUEEN S UNIVERSITY   (Canada)

^l UNIVERSITY OF ILLINOIS HOSPITAL AND HEALTH SCIENCES SYSTEM   (United States)

^m MAYO CLINIC   (United States)

ⁿ MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^o WEILL CORNELL MEDICAL COLLEGE   (United States)

^p ARIZONA STATE UNIVERSITY   (United States)

^q MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^r National Biomarker Development Alliance   (United States)

more..

Author keywords

decision making; evidence based medicine; patient preferences; personalized medicine

Indexed keywords

AMERICAN JOINT COMMITTEE ON CANCER; BREAST CANCER; CANCER PATIENT; CANCER STAGING; CHECKLIST; COLON CANCER; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; MEDICAL PRACTICE; MELANOMA; NOTE; OUTCOME ASSESSMENT; PERSONALIZED MEDICINE; PREDICTION; PRIORITY JOURNAL; PROFESSIONAL STANDARD; PROGNOSIS; PROSTATE CANCER; SOLID TUMOR; DECISION MAKING; EVIDENCE BASED MEDICINE; NEOPLASM; NON PROFIT ORGANIZATION; PATHOLOGY; RISK; UNITED STATES;

AMERICAN CANCER SOCIETY; DECISION MAKING; EVIDENCE-BASED MEDICINE; HUMANS; NEOPLASM STAGING; NEOPLASMS; PRECISION MEDICINE; PROGNOSIS; RISK; UNITED STATES;

EID: 84955072254     PISSN: 00079235     EISSN: 15424863     Source Type: Journal    
DOI: 10.3322/caac.21339     Document Type: Note

References (10)

1. Gospodarowicz M, Benedet L, Hutter RV, Fleming I, Henson DE, Sobin LH. History and international developments in cancer staging. Cancer Prev Control. 1998;2:262-268.
2. Asare EA, Washington MK, Gress DM, Gershenwald GE, Greene FL. Improving the quality of cancer staging. CA Cancer J Clin. 2015;65:261-263.
3. Gershenwald JE, Soong SJ, Balch CM; American Joint Committee on Cancer (AJCC) Melanoma Staging Committee. 2010 TNM staging system for cutaneous melanoma…and beyond. Ann Surg Oncol. 2010;17:1475-1477.
4. Reilly BM, Evans AT Translating clinical research into clinical practice: impact of using prediction rules to make decisions. Ann Intern Med. 2006;44:201-209.
5. Justice AC, Covinsky KE, Berlin JA. Assessing the generalizability of prognostic information. Ann Intern Med. 1999;130:515-524.
6. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695-706.
7. Steyerberg EW, Harrell FE Jr. Prediction models need appropriate internal, internal-external, and external validation [published online ahead of print April 18, 2015]. J Clin Epidemiol. doi: 10.1016/j.jclinepi.2015.04.005.
8. Harrell FE Jr, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA. 1982;247:2543-2546.
9. Collins GS, Ogundimu EO, Altman DG. Sample size considerations for the external validation of a multivariable prognostic model: a resampling study [published online ahead of print November 9, 2015]. Stat Med. doi: 10.1002/sim.6786.
10. Moons KG, Altman DG, Reitsma JB, et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162:W1-W73.